Edward Jones has upgraded CVS Health (NYSE:CVS) to buy from hold, citing a potential turnaround in its Aetna insurance business. The investment firm said it believes CVS (NYSE:CVS) will improve ...

On Thursday, Edward Jones, a financial services firm, upgraded CVS Health (NYSE:CVS) stock from Hold to Buy. The upgrade comes as the stock, which InvestingPro analysis shows is currently ...

Meanwhile, Edward Jones analyst Ashtyn Evans upgraded CVS Health stock to Buy from Hold, as he believes that the company ...

Edward Jones last night upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story” with the potential for new management improving in its health insurance ...

CVS Health (NYSE:CVS – Get Free Report) is projected to release its earnings data before the market opens on Wednesday, February 12th. Analysts expect CVS Health to post earnings of $0.89 per share ...

According to Edward Jones, “CVS has seen health care delivery costs rise as more seniors get procedures done. There also have been changes in the Medicare Advantage program along with CVS's own ...

CVS Health (NYSE:CVS – Free Report) had its target price increased by Wolfe Research from 67.00 to 70.00 in a report ...

Edward Jones upgraded CVS Health (CVS) to Buy from Hold. The company could be an attractive turnaround story" with the potential for new management improving in its health insurance division ...